Nasopharygeal carcinoma resisting active composition and chemotherapy drug as well as application of nasopharygeal carcinoma resisting active composition
A chemotherapy drug and technology for nasopharyngeal carcinoma, applied in drug combinations, antineoplastic drugs, inorganic active ingredients, etc., can solve the problems of low survival rate, large weight change, and large toxic and side effects of the patient, so as to improve the effect of chemotherapy and enhance the Effect, the effect of reducing IC50 value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] MTT method to detect the effect of DDP combined with the compound of formula 1 on the IC50 value of nasopharyngeal carcinoma cells
[0038] Human nasopharyngeal carcinoma cells HONE1-EBV grown in logarithmic phase + and 5-8F, after trypsinization for about five minutes, lightly suspend into a single cell suspension and count, adjust the number of cells to 5×10 in 100ul per well 3 After 24 hours of conventional culture, after the cells adhere to the wall and grow well, suck off the old culture medium (RPMI-1640), and add different concentrations of the compound of formula 1 and DDP liquid prepared from the culture medium, 0.01, 0.25, 0.5, Set five duplicate wells for each concentration of 0.75, 1μM, continue to cultivate for 48 hours, add 20μl of MTT, incubate in a 37° incubator for 4 hours, suck off the old medium containing MTT, add 150μl of DMSO to dissolve, and put it in a MultiskanSky microplate reader The absorbance value (OD value) of each well was detected with ...
Embodiment 2
[0042] Drug experiment in nude mice
[0043] will contain 5 x 10 6 HONE1-EBV overexpressing EBV-miR-BART22 + and 5-8F cells were injected into nude mice by intraperitoneal injection, and then the nude mice were randomly divided into four groups, 10 in each group. 10 days after injection, the first group received DDP treatment (4mg / kg), the second group received formula 1 compound treatment (4mg / kg), the third group DDP joint formula 1 compound treatment (total 4mg / kg; wherein, DDP, The ratio of the compound of formula 1 was 1:1); each group was administered by intraperitoneal injection every 5 days. The nude mice were weighed regularly, the survival of the nude mice was observed every day, and the time of death was recorded in time.
[0044] 1. Observation of kidney tissue morphology
[0045] 2. Result statistics
[0046] Survival analysis Grafpad was used to draw survival curves.
[0047] The results show:
[0048] The present invention adopts formula 1 compound and DD...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


